Research ArticleClinical Studies
Circulating Tumor Cells in Solid Tumor in Metastatic and Localized Stages
LUISA M. MAESTRO, JAVIER SASTRE, SARA B. RAFAEL, SILVIA B. VEGANZONES, MARTA VIDAURRETA, MIGUEL MARTÍN, CARLOS OLIVIER, VIRGINIA B. DE LA ORDEN, JOSE ANGEL GARCIA-SAENZ, ROSARIO ALFONSO, MANUEL ARROYO and EDUARDO DIAZ-RUBIO
Anticancer Research November 2009, 29 (11) 4839-4843;
LUISA M. MAESTRO
JAVIER SASTRE
SARA B. RAFAEL
SILVIA B. VEGANZONES
MARTA VIDAURRETA
MIGUEL MARTÍN
CARLOS OLIVIER
VIRGINIA B. DE LA ORDEN
JOSE ANGEL GARCIA-SAENZ
ROSARIO ALFONSO
MANUEL ARROYO
In this issue
Anticancer Research
Vol. 29, Issue 11
November 2009
Circulating Tumor Cells in Solid Tumor in Metastatic and Localized Stages
LUISA M. MAESTRO, JAVIER SASTRE, SARA B. RAFAEL, SILVIA B. VEGANZONES, MARTA VIDAURRETA, MIGUEL MARTÍN, CARLOS OLIVIER, VIRGINIA B. DE LA ORDEN, JOSE ANGEL GARCIA-SAENZ, ROSARIO ALFONSO, MANUEL ARROYO, EDUARDO DIAZ-RUBIO
Anticancer Research Nov 2009, 29 (11) 4839-4843;
Circulating Tumor Cells in Solid Tumor in Metastatic and Localized Stages
LUISA M. MAESTRO, JAVIER SASTRE, SARA B. RAFAEL, SILVIA B. VEGANZONES, MARTA VIDAURRETA, MIGUEL MARTÍN, CARLOS OLIVIER, VIRGINIA B. DE LA ORDEN, JOSE ANGEL GARCIA-SAENZ, ROSARIO ALFONSO, MANUEL ARROYO, EDUARDO DIAZ-RUBIO
Anticancer Research Nov 2009, 29 (11) 4839-4843;
Jump to section
Related Articles
Cited By...
- Short-term circulating tumor cell dynamics in mouse xenograft models and implications for liquid biopsy
- Analysis of circulating tumor cells in patients with hepatocellular carcinoma recurrence following liver transplantation
- Analysis of circulating tumor cells in patients with hepatocellular carcinoma recurrence following liver transplantation
- Diagnostic technologies for circulating tumour cells and exosomes
- Interleukin-17A Modulates Circulating Tumor Cells in Tumor Draining Vein of Colorectal Cancers and Affects Metastases
- Establishment and Validation of Circulating Tumor Cell-Based Prognostic Nomograms in First-Line Metastatic Breast Cancer Patients
- Baseline Circulating Tumor Cell Counts Significantly Enhance a Prognostic Score for Patients Participating in Phase I Oncology Trials
- Low Number of Detectable Circulating Tumor Cells in Non-metastatic Colon Cancer
- Improvement of Biodistribution with PEGylated Liposomes Containing Docetaxel with Degradable Starch Microspheres for Hepatic Arterial Infusion in the Treatment of Liver Metastases: A Study in CC-531 Liver Tumor-bearing WAG RIJ Rats







